Tissue Regenix looks to acquire CellRight

Writer, Stock Market Wire
Friday, May 19, 2017 - 14:08

Tissue Regenix Group said it has noted the recent application for a temporary restraining order filed by one of the members of CellRight Technologies, with Bexar County District Court against CellRight, in relation to a potential sale of CellRight to Tissue Regenix.

Tissue Regenix has confirmed that it is in discussions with CellRight regarding a possible acquisition of CellRight.

At 2:08pm: (LON:TRX) Tissue Regenix Group PLC share price was -0.25p at 14.75p


Related content

Tissue Regenix secures additional coverage in the US for DermaPure

Tissue Regenix secured additional coverage with a US Group Purchasing Organization (GPO) for the use of DermaPure, a decellularized allograft dermis.

The company said the...

Thu, 04/04/2019 - 07:48


Tissue Regenix moves closer to profitability after revenue jumps

Regenerative medical devices company Tissue Regenix Group said it expected to move closer to its goal of generating 'sustainable profitability' in 2019 after it more...

Mon, 04/02/2019 - 14:17


Tissue Regenix signs European distribution agreement with Arthrex

Regenerative medical devices company Tissue Regenix Group said it had entered into an agreement allowing Arthrex to distribute its BioRinse bone portfolio throughout Europe, with...

Tue, 13/11/2018 - 09:19


Tissue Regenix confirms new CFO appointment

Manchester-based medical devices company Tissue Regenix Group confirmed that Gareth Jones had officially taken up the role of chief financial officer.

His appointment had been...

Mon, 29/10/2018 - 07:54


Tissue Regenix posts loss as costs offset higher revenue

Regenerative medical devices company Tissue Regenix Group posted a first-half loss, as higher revenue was offset by costs.

Pre-tax losses for the six months through...

Mon, 03/09/2018 - 09:21